Clinical Trial Update: Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE) [Phase 3]

View source ↗

Summary

Phase 3 trial updating efficacy and safety of benralizumab in uncontrolled asthma patients on medium-high dose ICS/LABA (MIRACLE) completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Benralizumab (benralizumab)

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Phase 3 | Status: COMPLETED | Results posted: 2024-04-24